V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 160011798 | 160011595 | 1.83 | 47.6 | null | 2018-09-13 | 2018-09-27 | Doxorubicin 75mg/m2 | null | null | VINORELBINE | 101828336 |
| 160011803 | 160011596 | 1.73 | 70.8 | null | 2017-09-16 | 2017-09-23 | Trabectedin | 02 | null | TRABECTEDIN | 101108280 |
| 160011806 | 160011597 | 1.62 | 56.6 | Palliative (P) | 2017-12-06 | 2017-12-10 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101491986 |
| 160011815 | 160011598 | 1.83 | 74.2 | Palliative (P) | 2021-05-30 | 2021-06-22 | Doxorubicin 75mg/m2 | 02 | N | TRIAL UNSPECIFIED | 100639775 |
| 160011817 | 160011599 | 1.67 | 82.35 | Palliative (P) | 2020-12-28 | 2021-01-12 | Doxorubicin 75mg/m2 | 02 | N | TRIAL UNSPECIFIED | 100788363 |
| 160011823 | 160011600 | 1.6 | 87 | Palliative (P) | 2020-06-23 | 2020-07-23 | VINORELBINE | 02 | N | VINORELBINE | 100291168 |
| 160011826 | 160011601 | 1.63 | 78.7 | null | 2018-09-19 | 2018-09-19 | VINORELBINE | 02 | null | VINORELBINE | 101126680 |
| 160011827 | 160011602 | 1.76 | 21.2 | Palliative (P) | 2019-08-08 | 2019-08-24 | Trabectedin | null | null | TRABECTEDIN | 101237860 |
| 160011828 | 160011603 | 1.81 | 57.7 | null | 2019-04-06 | 2019-04-12 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 101077260 |
| 160011829 | 160011604 | 1.66 | 85.8 | Palliative (P) | 2018-12-29 | 2019-03-09 | Doxorubicin 75mg/m2 | 02 | N | DOXORUBICIN | 100823979 |
| 160011835 | 160011605 | 1.61 | 71.05 | null | 2020-12-26 | 2020-12-27 | NIVOLUMAB | 02 | null | NIVOLUMAB | 100600894 |
| 160011841 | 160011606 | 1.69 | 66.8 | Palliative (P) | 2017-06-02 | 2017-06-05 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100953140 |
| 160011842 | 160011607 | 1.74 | 126 | Palliative (P) | 2020-04-28 | 2020-04-29 | NIVOLUMAB | 02 | Y | NIVOLUMAB | 100734650 |
| 160011844 | 160011608 | 1.59 | 104 | Palliative (P) | 2018-10-24 | 2019-04-23 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100707875 |
| 160011846 | 160011609 | 1.82 | 88 | Palliative (P) | 2018-11-30 | 2018-12-17 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101320607 |
| 160011850 | 160011610 | 1.74 | 82.7 | null | 2021-01-20 | 2021-01-20 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 101054308 |
| 160011851 | 160011611 | null | 89 | null | 2019-11-21 | 2019-12-11 | NIVOLUMAB | 02 | null | NIVOLUMAB | 101068255 |
| 160011853 | 160011612 | 1.79 | 108.8 | null | 2018-07-06 | 2018-07-06 | Doxorubicin 75mg/m2 | null | null | DOXORUBICIN | 101790302 |
| 160011855 | 160011613 | 1.6 | 76.9 | Palliative (P) | 2018-02-09 | 2018-02-09 | Trial Unspecified | 02 | N | TRIAL UNSPECIFIED | 100261055 |
| 160011858 | 160011614 | 1.62 | 57 | null | 2018-06-06 | 2018-06-20 | Trabectedin | 02 | null | TRABECTEDIN | 100211640 |
| 160011859 | 160011615 | 1.73 | 78.5 | null | 2018-07-23 | 2018-07-23 | Trial Unspecified | 02 | null | TRIAL UNSPECIFIED | 101550719 |
| 160011860 | 160011616 | 1.67 | 104.3 | Neo-adjuvant (N) | 2020-03-18 | 2020-03-20 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100322357 |
| 160011861 | 160011617 | 1.63 | 81.4 | Palliative (P) | 2017-04-23 | 2017-05-13 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101401112 |
| 160011865 | 160011618 | 1.83 | 105 | Palliative (P) | 2020-09-15 | 2020-09-16 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100267955 |
| 160011877 | 160011619 | 1.72 | 55.2 | Palliative (P) | 2018-03-29 | 2018-12-11 | DOXORUBICIN | 02 | N | NIVOLUMAB | 100701304 |
| 160011881 | 160011620 | 1.64 | 74.65 | Palliative (P) | 2018-05-06 | 2018-05-26 | DOXORUBICIN | 02 | N | DOXORUBICIN | 100489993 |
| 160011885 | 160011621 | 0 | 120.8 | null | 2019-01-16 | 2019-01-16 | Doxorubin 50mg/m2 | N | null | TRIAL UNSPECIFIED | 100855560 |
| 160011892 | 160011622 | 1.6 | 74.8 | Palliative (P) | 2018-10-18 | 2018-10-18 | Vinorelbine (oral) | 02 | N | VINORELBINE | 100836342 |
| 160011896 | 160011623 | 1.68 | 91.8 | null | 2019-08-27 | 2019-09-04 | Vinorelbine (oral) | 02 | null | VINORELBINE | 101692073 |
| 160011897 | 160011624 | 1.79 | 83.2 | null | 2017-02-26 | 2017-03-07 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 101166566 |
| 160011900 | 160011625 | 1.62 | 60.5 | Palliative (P) | 2017-01-07 | 2017-01-08 | DOXORUBICIN | 02 | N | NIVOLUMAB | 101184774 |
| 160011911 | 160011626 | 1.79 | 83 | null | 2019-04-29 | 2019-05-27 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 100335096 |
| 160011913 | 160011627 | 1.68 | 69.6 | null | 2020-11-13 | 2021-03-13 | Vinorelbine (oral) | 02 | null | VINORELBINE | 101344699 |
| 160011917 | 160011628 | 1.71 | 73.8 | null | 2018-06-09 | 2018-06-09 | Trabectedin | 02 | null | TRABECTEDIN | 101465451 |
| 160011923 | 160011630 | 1.74 | 52.8 | null | 2019-12-14 | 2019-12-14 | Trial Unspecified | 02 | null | TRIAL UNSPECIFIED | 100292073 |
| 160011924 | 160011631 | 1.82 | null | Palliative (P) | 2017-08-19 | 2018-01-30 | Doxorubin 50mg/m2 | 02 | N | NIVOLUMAB | 101650182 |
| 160011927 | 160011632 | 1.73 | 50.8 | null | 2018-01-31 | 2018-02-12 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 101634702 |
| 160011928 | 160011633 | 1.72 | 87.9 | null | 2017-01-27 | 2017-02-13 | Trabectedin | null | null | TRABECTEDIN | 100754008 |
| 160011931 | 160011634 | 1.74 | 64.5 | Palliative (P) | 2019-11-16 | 2019-11-25 | Vinorelbine (weekly iv) | 02 | N | VINORELBINE | 100837576 |
| 160011936 | 160011635 | 1.6 | 45 | Curative (C) | 2018-03-02 | 2018-03-16 | Doxorubicin 75mg/m2 | 02 | N | TRIAL UNSPECIFIED | 101814689 |
| 160011938 | 160011636 | 1.65 | 80.25 | null | 2019-12-17 | 2019-12-25 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 100718439 |
| 160011940 | 160011637 | 1.72 | 70.8 | null | 2016-12-20 | 2018-01-17 | DOXORUBICIN | 02 | null | DOXORUBICIN | 101187251 |
| 160011942 | 160011638 | 1.56 | 72.4 | null | 2020-12-06 | 2021-02-25 | DOXORUBICIN | 02 | null | DOXORUBICIN | 101322762 |
| 160011948 | 160011639 | 1.75 | 67.8 | null | 2018-06-04 | 2018-06-04 | Trabectedin | 02 | null | TRABECTEDIN | 101247845 |
| 160011949 | 160011640 | 1.91 | 55.2 | Palliative (P) | 2020-06-13 | 2020-06-13 | DOXORUBICIN | 02 | N | DOXORUBICIN | 100037829 |
| 160011952 | 160011641 | 1.79 | 59.4 | Palliative (P) | 2018-11-09 | 2018-11-22 | Vinorelbine (weekly iv) | 02 | N | VINORELBINE | 100295633 |
| 160011966 | 160011642 | 1.81 | 99 | Palliative (P) | 2018-12-27 | 2018-12-27 | DOXORUBICIN | 02 | N | DOXORUBICIN | 100518195 |
| 160011968 | 160011643 | 1.72 | 64.8 | Palliative (P) | 2020-02-29 | 2020-03-24 | Doxorubicin 75mg/m2 | 02 | null | TRABECTEDIN | 101480548 |
| 160011971 | 160011644 | 1.7 | 105 | Palliative (P) | 2018-07-03 | 2018-07-08 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101645339 |
| 160011973 | 160011645 | 1.6 | 82.2 | null | 2017-03-01 | 2017-08-01 | Doxorubicin 75mg/m2 | 02 | null | TRIAL UNSPECIFIED | 100453317 |